Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Wafaa El‐Akel"'
Autor:
Ahmed Moustafa, Mohamed AbdAllah, Wafaa El Akel, Sherif Wahed, Shereen Abdel Alem, Gamal Esmat
Publikováno v:
Egyptian Liver Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Background and purpose of the study Sickle cell disease (SCD) patients are at a high risk of chronic liver disease (CLD) due to chronic viral hepatitis infection such as hepatitis C virus (HCV) infection, iron overload, and sickle cell hepat
Externí odkaz:
https://doaj.org/article/1560c5b2ebf744159dfb92060df7b924
Autor:
Gamal Esmat, Hala Zaid, Mohamed Hassany, Wael Abdel-Razek, Magdy El-Serafy, Wafaa El Akel, Aysam Salah, Ehab Kamal, Galal Elshishiney, Islam Ammar, Khaled Kabil, Mohamed AbdAllah, Ramy Saeed, Tarek Saad, Yasser Omar, Hany Dabbous, Manal H. El-Sayed, Yehia El Shazly, Wahid Doss, Imam Waked
Publikováno v:
Egyptian Liver Journal, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Obesity is a global health problem and has been increasing in Egypt over the last several decades. A national population screening program for hepatitis C included screening for obesity. Here we report the outcome of body mass index (BMI) ca
Externí odkaz:
https://doaj.org/article/15e05e44373e4f3a82c179f9968f1246
Autor:
Dina Attia, Shereen Abdel Alem, Wafaa El‐Akel, Wael Abdel‐Razek, Mohamed Eslam, Yasser Fouad, Imam Waked
Publikováno v:
Alimentary Pharmacology & Therapeutics. 56:1581-1590
Metabolic-associated fatty liver disease (MAFLD) was proposed in 2020 to identify fatty liver disease associated with metabolic risks. Metabolic abnormalities with hepatitis C virus (HCV) and MAFLD frequently co-exist. However, data on the co-existen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::434501fe0a5974edacf0ed2b8c97fc28
https://doi.org/10.1111/apt.17233
https://doi.org/10.1111/apt.17233
Autor:
Sameera Ezzat, Ivane Gamkrelidze, Alaa Osman, Asmaa Gomaa, Ayat Roushdy, Gamal Esmat, Homie Razavi, Sarah Blach, Wael Abdel‐Razek, Wafaa El‐Akel, Imam Waked
Publikováno v:
Liver International.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a996b127a513c8dd8df05bc9eecff39c
https://doi.org/10.1111/liv.15584
https://doi.org/10.1111/liv.15584
Autor:
Mahmoud ElHefnawi, Wafaa El-Akel, Mohamed M. Ezz, Shehab Gamalel-Din, Shimaa M. Abd-Elsalam, Gamal Esmat
Publikováno v:
Journal of Advanced Research, Vol 35, Iss, Pp 87-97 (2022)
Journal of Advanced Research
Journal of Advanced Research
Graphical abstract
Highlights • Esophageal Varices is one complication of chronic liver disease that leads to deaths globally due to hemorrhage. • The prediction of presence the Esophageal Varices is essential to avoid bleeding for patients.
Highlights • Esophageal Varices is one complication of chronic liver disease that leads to deaths globally due to hemorrhage. • The prediction of presence the Esophageal Varices is essential to avoid bleeding for patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e83702b54d39b83c822588bd24ab206b
https://doi.org/10.1016/j.jare.2021.02.005
https://doi.org/10.1016/j.jare.2021.02.005
Autor:
Mohamed AbdAllah, Mahmoud Essam, Mohamed Samir Abd Elghafar, Tamer Elhadidy, Gamal Esmat, Marwa Salama, Tamer Elbaz, Mustafa Neamatallah, Mostafa Elshazly, Ahmed Cordie, Mahmoud El-Bendary, Wafaa El-Akel, Khaled Farid, Mohamed Elegezy, Adel El-Badrawy, Sherief Abd-Elsalam, Hatem Elalfy
Publikováno v:
Expert Review of Anti-infective Therapy. 20:291-295
Limited experimental and clinical evidence suggests a potential role for sofosbuvir/daclatasvir in treating COVID19. We aim to evaluate the efficacy of generic sofosbuvir/daclatasvir in treating CO...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::812d196460d07fac296b2f47aa8ecd28
https://doi.org/10.1080/14787210.2021.1950532
https://doi.org/10.1080/14787210.2021.1950532
Autor:
Rabab Salama, Naglaa Zayed, Aisha Elsharkawy, Iman Ramzy, Zeinab Abdellatif, Nader Gamal, Marwa Elsharkawy, Rabab Fouad, Wafaa El Akel
Publikováno v:
Arab Journal of Gastroenterology. 22:6-11
BACKGROUND AND STUDY AIMS Assessing the extent of fibrosis is an essential part of therapeutic decisions in patients with chronic hepatitis C (CHC). Liver biopsies are the "gold standard" for evaluating liver fibrosis but have many limitations. Thus,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c64cb95d44f651222965fca1808018f6
https://doi.org/10.1016/j.ajg.2020.12.003
https://doi.org/10.1016/j.ajg.2020.12.003
Autor:
Ahmed M. Hashem, Shimaa Mansour, Mariam Naguib, Amal Helmy, Mohamed Hassany, Nahla Khalaf, Rasha Eletreby, Abdelrahman Kobtan, Gamal Esmat, Mahmoud Anees, Wahid Doss, Wafaa El Akel
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 15:103-110
This study aims to assess the changes of lipid profile in chronic HCV patients; before, during, and after treatment with DAAs and their association with treatment response.301 chronic HCV patients who received SOF-based therapy were included. Serum l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a15816f4f37d3835f3baf7e1dd09cb
https://doi.org/10.1080/17474124.2020.1823831
https://doi.org/10.1080/17474124.2020.1823831
Autor:
Wahid Doss, Arwa M. Hosny El-Shafei, Mai Mehrez, Manal H El-Sayed, Dina zeyada, Magdy Alserafy, Mohamed Said, Emam Waked, Wafaa El-Akel, Mohamed Hassany, Maysa elrazky, Gamal Esmat, Mahmoud Anis, Hend Ibrahim Shousha
Publikováno v:
Journal of Infection and Public Health, Vol 13, Iss 9, Pp 1322-1329 (2020)
Background The national committee for control of viral hepatitis (NCCVH) in Egypt, settled by the Ministry of health, treated over one million patients in around 60 centers with chronological changes in drug combinations. This research aims to study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd0be9051eca54fcab7678332febc0d9
https://doi.org/10.1016/j.jiph.2020.05.008
https://doi.org/10.1016/j.jiph.2020.05.008
Autor:
Wael Shehata, Ahmed Rehan, Islam Ammar, Adel Tealaab, Aysam Salah, Tamer Marei, Alsayeda Meshref, Galal Elshishiney, Reham Ghalab, Khalid Abou Hashem, Nevine El Nahas, Naseif Hefnawy, Amal Hashem, Ehab Kamal, Hesham Shawky, Mohamed Shawky, Yasser Omar, Mohamed Hassany, Hala Zaid, Yehia El Shazly, Imam Waked, Gamal Esmat, Omnia Ragab, Ahmed El Sobky, Manal H El-Sayed, Sahar El Sonbaty, Tarek Saad, Ahmed Cordie, Wafaa El Akel, Mohamed Zein, Ramy Saeed, Sayed Abdel Gawad, Magdy El-Serafy, Hany Dabbous, Abdel N Hemida, Hany Gemeah, Alaa Hashish, Mohsen Taha, Khaled Kabil, Kamal Labib, Saad Mekky, Faisal Mahmoud, Aisha Elsharkawy, Wahid Doss, Soad Abdel Megid, Elhag Ramadan, Hamdy El Tabakh, Mohamed Sharshar, Wael Abdel-Razek, Mahmoud Talha, Ehab Emad, Mohamed S. Hashim AbdAlla, Mohamed Abo Sliman, Said Mamoun, Ayman Khadary, Alaa Othman, Hanaa Soror
Publikováno v:
New England Journal of Medicine. 382:1166-1174
Screening Program to Eliminate Hepatitis C in Egypt In 2018, the Egyptian government initiated a massive hepatitis C screening and treatment program. The Ministry of Health set the goal of screenin...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afd396e72748edb430b23ffe550cd9ca
https://doi.org/10.1056/nejmsr1912628
https://doi.org/10.1056/nejmsr1912628